Quick Takeaways
- David P. Perry has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,695,296.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David P. Perry
- Location
- Palo Alto, CA
- Summary
- The estimated net worth of David P. Perry is at least $3,695,296 dollars as of 13 Feb 2024. David P. Perry is the Executive Chairman, Director, 10%+ Owner of Better Therapeutics, Inc. and owns shares of Better Therapeutics, Inc. (BTTX) stock worth about $3.7M.
- Signature
- /s/ Shoaib Ghias, Attorney-in-Fact for David P. Perry
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David P. Perry and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Better Therapeutics, Inc. ($3,695,296).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David P. Perry
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BTTX | Better Therapeutics, Inc. | Executive Chairman, Director, 10%+ Owner | $3,695,296 | 09 Feb 2024 | ||
| EVLO | Evelo Biosciences, Inc. | Director | 08 Jun 2021 |
Insider Transactions Reported by David P. Perry:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.